Sioux Pharm

Sioux Pharm is a U.S.-based pharmaceutical ingredient manufacturer focused on biologically derived chondroitin sulfate. The company was founded in 1998 in Sioux Center, Iowa, and operates a GMP manufacturing facility that isolates natural products from animal tissues. Its primary commercial product is chondroitin sulfate sodium, supplied as an active pharmaceutical ingredient with regulatory support including US DMF and CEP/COS listings. Sioux Pharm appears to have been sold from its original founder and is associated with Bioiberica operationally, while continuing to operate under the Sioux Pharm name. The business is healthcare-related, but it is not a drug discovery biotech with a therapeutic pipeline; rather, it is a commercial specialty manufacturer serving pharmaceutical and related health markets.